Richard Justice
Finanzdirektor/CFO bei Mie Pay Ltd.
Profil
Richard Justice is currently the Chief Financial Officer at Mie Pay Ltd.
He previously worked as a Secretary at New Talisman Gold Mines Ltd., and as the Chief Financial Officer at Algorae Pharmaceuticals Ltd.
and Photonz Corp.
Ltd.
Mr. Justice obtained an undergraduate degree and an MBA from Auckland University.
Aktive Positionen von Richard Justice
| Unternehmen | Position | Beginn |
|---|---|---|
Mie Pay Ltd.
 Mie Pay Ltd. Packaged SoftwareTechnology Services Mie Pay Ltd. is a holding company, which engages in the provision of E-commerce and payments platform. The company was founded on November 1, 2018 and is headquartered in Sydney, Australia. | Finanzdirektor/CFO | 04.11.2019 |
Ehemalige bekannte Positionen von Richard Justice
| Unternehmen | Position | Ende |
|---|---|---|
| ALGORAE PHARMACEUTICALS LIMITED | Finanzdirektor/CFO | - |
| NEW TALISMAN GOLD MINES LIMITED | Unternehmenssekretär | - |
Photonz Corp. Ltd.
 Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Finanzdirektor/CFO | - |
Ausbildung von Richard Justice
| Auckland University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEW TALISMAN GOLD MINES LIMITED | Non-Energy Minerals |
| ALGORAE PHARMACEUTICALS LIMITED | Health Technology |
 | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Photonz Corp. Ltd.
Photonz Corp. Ltd. BiotechnologyHealth Technology Photonz Corp. Ltd. operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid. Its products include PNZC0901, a fermentation drug substance comprising high purity eicosapentaenoic acid. The company was founded by Karl Thomas Geiringer on April 17, 2015 and is headquartered in Auckland, New Zealand. | Health Technology |
